| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10595158 | Bioorganic & Medicinal Chemistry Letters | 2012 | 4 Pages |
Abstract
Over the last few years, BRAF has emerged as a validated target in melanoma. This review summarises recent advances in the development of BRAF inhibitors, focussing on agents that have been assessed clinically.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Alfonso Zambon, Ion Niculescu-Duvaz, Dan Niculescu-Duvaz, Richard Marais, Caroline J Springer,